Fuller & Thaler Asset Management Inc. Cuts Stock Position in Chemed Co. (NYSE:CHE)

Fuller & Thaler Asset Management Inc. cut its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 17.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 37,224 shares of the company's stock after selling 7,765 shares during the period. Fuller & Thaler Asset Management Inc. owned about 0.25% of Chemed worth $19,721,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. CIBC Asset Management Inc lifted its holdings in Chemed by 5.1% in the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock valued at $242,000 after acquiring an additional 22 shares during the period. CBIZ Investment Advisory Services LLC grew its position in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after buying an additional 22 shares during the period. CIBC Private Wealth Group LLC increased its holdings in Chemed by 13.5% during the fourth quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock valued at $98,000 after buying an additional 22 shares during the last quarter. Independent Advisor Alliance raised its position in Chemed by 1.1% in the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company's stock worth $1,207,000 after acquiring an additional 25 shares during the period. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Chemed by 7.1% in the 4th quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company's stock worth $264,000 after purchasing an additional 33 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. This represents a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 3.29% of the stock is owned by insiders.

Chemed Trading Up 1.7 %

Shares of NYSE:CHE traded up $9.58 during mid-day trading on Monday, reaching $565.32. The stock had a trading volume of 115,588 shares, compared to its average volume of 98,797. The business's 50 day moving average price is $587.84 and its 200 day moving average price is $566.56. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $623.61. The company has a market cap of $8.26 billion, a P/E ratio of 28.57, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating the consensus estimate of $5.59 by $0.04. The business had revenue of $646.94 million during the quarter, compared to analyst estimates of $641.78 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. Chemed's quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter last year, the business earned $5.20 earnings per share. Analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date was Monday, February 24th. Chemed's dividend payout ratio (DPR) is currently 9.74%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on CHE. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank of Canada upped their price target on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research note on Monday.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.